Detail publikačního výsledku

Digital PCR in noninvasive prenatal testing: Analytical principles, clinical utilities, and future integration

ZENG, W.; LUO, W.; ZHOU, J.; WANG, B.; QIN, H.; HE, Y.; GABLECH, I.; KORABECNA, M.; NEUŽIL, P.

Originální název

Digital PCR in noninvasive prenatal testing: Analytical principles, clinical utilities, and future integration

Anglický název

Digital PCR in noninvasive prenatal testing: Analytical principles, clinical utilities, and future integration

Druh

Článek WoS

Originální abstrakt

Digital PCR (dPCR) enables absolute nucleic acid quantification through partition-based amplification and has emerged as a robust analytical platform for non-invasive prenatal testing (NIPT). Direct molecular counting, independent of calibration curves and amplification efficiency, enables precise detection of chromosomal aneuploidies, rare paternal or de novo variants, and microdeletions at very low fetal DNA fractions where sequencing-based screening loses statistical power. High partition numbers, strong reproducibility, and minimal computational requirements distinguish dPCR from qPCR and next-generation sequencing (NGS), positioning it as a reliable confirmatory method for sequencing-derived findings. Analytical advances, including improved extraction efficiency, enhanced partition stability, expanded multiplexing strategies, and duplex ratio assays, further improve performance in complex plasma samples. Hybrid workflows integrating NGS-based genomewide discovery with dPCR-based quantitative validation reduce false positives and enhance diagnostic confidence. Digital PCR thus complements sequencing and supports a precise and scalable framework for nextgeneration prenatal diagnostics.

Anglický abstrakt

Digital PCR (dPCR) enables absolute nucleic acid quantification through partition-based amplification and has emerged as a robust analytical platform for non-invasive prenatal testing (NIPT). Direct molecular counting, independent of calibration curves and amplification efficiency, enables precise detection of chromosomal aneuploidies, rare paternal or de novo variants, and microdeletions at very low fetal DNA fractions where sequencing-based screening loses statistical power. High partition numbers, strong reproducibility, and minimal computational requirements distinguish dPCR from qPCR and next-generation sequencing (NGS), positioning it as a reliable confirmatory method for sequencing-derived findings. Analytical advances, including improved extraction efficiency, enhanced partition stability, expanded multiplexing strategies, and duplex ratio assays, further improve performance in complex plasma samples. Hybrid workflows integrating NGS-based genomewide discovery with dPCR-based quantitative validation reduce false positives and enhance diagnostic confidence. Digital PCR thus complements sequencing and supports a precise and scalable framework for nextgeneration prenatal diagnostics.

Klíčová slova

Droplet digital polymerase chain reaction, Noninvasive prenatal testing, Cell-free fetal DNA (cffDNA), Next-generation sequencing

Klíčová slova v angličtině

Droplet digital polymerase chain reaction, Noninvasive prenatal testing, Cell-free fetal DNA (cffDNA), Next-generation sequencing

Autoři

ZENG, W.; LUO, W.; ZHOU, J.; WANG, B.; QIN, H.; HE, Y.; GABLECH, I.; KORABECNA, M.; NEUŽIL, P.

Rok RIV

2026

Vydáno

01.04.2026

Nakladatel

Elsevier

Periodikum

TRAC-TRENDS IN ANALYTICAL CHEMISTRY

Svazek

197

Číslo

4

Stát

Spojené království Velké Británie a Severního Irska

Strany počet

14

URL

BibTex

@article{BUT201735,
  author="{} and  {} and  {} and  {} and  {} and  {} and Imrich {Gablech} and  {} and Pavel {Neužil}",
  title="Digital PCR in noninvasive prenatal testing: Analytical principles, clinical utilities, and future integration",
  journal="TRAC-TRENDS IN ANALYTICAL CHEMISTRY",
  year="2026",
  volume="197",
  number="4",
  pages="14",
  doi="10.1016/j.trac.2026.118695",
  issn="0165-9936",
  url="https://www.sciencedirect.com/science/article/pii/S0165993626000506"
}